Endotoxaemia and complement activation in acute pancreatitis in man. 1982

A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley

Twenty-four patients who experienced 26 attacks of acute pancreatitis were studied. Endotoxaemia, as measured by the limulus lysate assay, was present in 13 of the attacks. Six out of seven patients with systemic complications of the disease had endotoxaemia. C3 catabolism was increased in all 26 attacks of pancreatitis, and a falling level of C3 during attacks of severe pancreatitis was associated with a fatal outcome. There was statistical evidence of more complement activation in serum samples taken when patients had positive limulus lysate tests than when endotoxin was not detected in their blood.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
November 1982, Gut,
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
April 1985, Scandinavian journal of gastroenterology,
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
July 1972, Lancet (London, England),
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
June 1972, Lancet (London, England),
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
June 1972, Lancet (London, England),
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
January 1986, Advances in experimental medicine and biology,
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
October 1976, Zeitschrift fur Gastroenterologie,
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
July 1990, Archives of surgery (Chicago, Ill. : 1960),
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
January 2006, Pancreas,
A K Foulis, and W R Murray, and D Galloway, and A C McCartney, and E Lang, and J Veitch, and K Whaley
July 1987, The Journal of pathology,
Copied contents to your clipboard!